Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL AUTO-INJECTORS INDUSTRY
2.1 Summary about Auto-Injectors Industry
2.2 Auto-Injectors Market Trends
2.2.1 Auto-Injectors Production & Consumption Trends
2.2.2 Auto-Injectors Demand Structure Trends
2.3 Auto-Injectors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Disposable Auto-Injectors
4.2.2 Reusable Auto-Injectors
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Anaphylaxis
4.3.2 Multiple Sclerosis
4.3.3 Rheumatoid Arthritis
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Disposable Auto-Injectors
5.2.2 Reusable Auto-Injectors
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Anaphylaxis
5.3.2 Multiple Sclerosis
5.3.3 Rheumatoid Arthritis
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Disposable Auto-Injectors
6.2.2 Reusable Auto-Injectors
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Anaphylaxis
6.3.2 Multiple Sclerosis
6.3.3 Rheumatoid Arthritis
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Disposable Auto-Injectors
7.2.2 Reusable Auto-Injectors
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Anaphylaxis
7.3.2 Multiple Sclerosis
7.3.3 Rheumatoid Arthritis
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Disposable Auto-Injectors
8.2.2 Reusable Auto-Injectors
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Anaphylaxis
8.3.2 Multiple Sclerosis
8.3.3 Rheumatoid Arthritis
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Disposable Auto-Injectors
9.2.2 Reusable Auto-Injectors
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Anaphylaxis
9.3.2 Multiple Sclerosis
9.3.3 Rheumatoid Arthritis
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Mylan
10.1.2 BD
10.1.3 Johnson & Johnson
10.1.4 Amgen Inc.
10.1.5 Eli Lilly
10.1.6 Biogen Idec
10.1.7 Bayer
10.1.8 Meridian (Pfizer)
10.1.9 Ypsomed Holding
10.1.10 Kaleo, Inc.
10.1.11 Owen Mumford
10.1.12 Antares Pharma, Inc.
10.1.13 Medeca Pharma AB
10.2 Auto-Injectors Sales Date of Major Players (2017-2020e)
10.2.1 Mylan
10.2.2 BD
10.2.3 Johnson & Johnson
10.2.4 Amgen Inc.
10.2.5 Eli Lilly
10.2.6 Biogen Idec
10.2.7 Bayer
10.2.8 Meridian (Pfizer)
10.2.9 Ypsomed Holding
10.2.10 Kaleo, Inc.
10.2.11 Owen Mumford
10.2.12 Antares Pharma, Inc.
10.2.13 Medeca Pharma AB
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Auto-Injectors Product Type Overview
Table Auto-Injectors Product Type Market Share List
Table Auto-Injectors Product Type of Major Players
Table Brief Introduction of Mylan
Table Brief Introduction of BD
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Amgen Inc.
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Biogen Idec
Table Brief Introduction of Bayer
Table Brief Introduction of Meridian (Pfizer)
Table Brief Introduction of Ypsomed Holding
Table Brief Introduction of Kaleo, Inc.
Table Brief Introduction of Owen Mumford
Table Brief Introduction of Antares Pharma, Inc.
Table Brief Introduction of Medeca Pharma AB
Table Products & Services of Mylan
Table Products & Services of BD
Table Products & Services of Johnson & Johnson
Table Products & Services of Amgen Inc.
Table Products & Services of Eli Lilly
Table Products & Services of Biogen Idec
Table Products & Services of Bayer
Table Products & Services of Meridian (Pfizer)
Table Products & Services of Ypsomed Holding
Table Products & Services of Kaleo, Inc.
Table Products & Services of Owen Mumford
Table Products & Services of Antares Pharma, Inc.
Table Products & Services of Medeca Pharma AB
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Auto-Injectors Market Forecast (Million USD) by Region 2021f-2026f
Table Global Auto-Injectors Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Auto-Injectors Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Auto-Injectors Market Forecast (Million USD) Share by Demand 2021f-2026f